Source:http://linkedlifedata.com/resource/pubmed/id/12699389
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2003-4-17
|
pubmed:abstractText |
The ATP-dependent drug efflux pump P-glycoprotein (P-gp) affects the absorption and disposition of many compounds. P-gp may also play role in clinically significant drug-drug interactions. Therefore, it is important to find potential substrates or inhibitors of P-gp early in the drug discovery process. To identify compounds that interact with this transporter, several P-gp assays were validated and compared by testing a set of 28 reference compounds, including inhibitors of cytochrome P450 3A4 (CYP3A4). The assays included in silico predictions, inhibition assays (based on cellular uptake of rhodamine-123 or calcein AM), and functional assays (ATPase activity assay and transcellular transport assay, the latter for a subset of compounds). In addition, species differences were studied in an indirect fluorescence indicator screening assay and test systems expressing porcine, mouse, or human P-gp. Our results suggest that several P-gp assays should be used in combination to classify compounds as substrates or inhibitors of P-gp. Recommendations are given on screening strategies which can be applied to different phases of the drug discovery and development process.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine Triphosphatases,
http://linkedlifedata.com/resource/pubmed/chemical/Fluoresceins,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorescent Dyes,
http://linkedlifedata.com/resource/pubmed/chemical/Indicators and Reagents,
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoprotein,
http://linkedlifedata.com/resource/pubmed/chemical/Rhodamines,
http://linkedlifedata.com/resource/pubmed/chemical/calcein AM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
24
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1716-25
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12699389-Adenosine Triphosphatases,
pubmed-meshheading:12699389-Animals,
pubmed-meshheading:12699389-Biological Transport,
pubmed-meshheading:12699389-Cells, Cultured,
pubmed-meshheading:12699389-Drug Evaluation, Preclinical,
pubmed-meshheading:12699389-Fluoresceins,
pubmed-meshheading:12699389-Fluorescent Dyes,
pubmed-meshheading:12699389-Humans,
pubmed-meshheading:12699389-Indicators and Reagents,
pubmed-meshheading:12699389-Mice,
pubmed-meshheading:12699389-Models, Molecular,
pubmed-meshheading:12699389-P-Glycoprotein,
pubmed-meshheading:12699389-Rhodamines,
pubmed-meshheading:12699389-Species Specificity,
pubmed-meshheading:12699389-Swine
|
pubmed:year |
2003
|
pubmed:articleTitle |
Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.
|
pubmed:affiliation |
F. Hoffmann-LaRoche Ltd., Pharmaceuticals Division, CH-4070 Basel, Switzerland.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Validation Studies
|